Juan Alberto Arnaiz Gargallo

Professor agregat

Àrea de coneixement : Farmacologia

Grup de Recerca: Farmacologia Clínica i Farmacogenètica

Informació de contacte
Departament de Fonaments Clínics
Servei de Farmacologia Clínica Hospital Clínic Villarroel 170
932279838
jaarnaiz(a)ub.edu

Docència Impartida

Síndrome d'Immunodeficiència Adquirida (Grau) - Medicina - Universidad de Barcelona.
Farmacologia (Grau) - Ciències Mèdiques Bàsiques - Universidad de Barcelona.
Farmacogenètica de les Malalties Psiquiàtriques (Màster oficial) - Competències Mèdiques Avançades - Universidad de Barcelona.
Farmacologia General (Grau) - Medicina - Universidad de Barcelona.
Farmacologia Clínica (Grau) - Medicina - Universidad de Barcelona.
Patologia Molecular i Terapèutica (Grau) - Enginyeria Biomèdica - Universidad de Barcelona.
Farmacologia (Grau) - Ciències Biomèdiques - Universidad de Barcelona.
Del Laboratori al Pacient: Translació a la Clínica dels Avenços en Investigació Biomèdica (Màster oficial) - Biomedicina - Universidad de Barcelona.
Máster de Sida Curso Básico de Sida: clínica, tratamiento y virología. Tratamiento del VHB y VHC en pacientes coinfectados VIH. VIH y hepatitis. Epidemiología y Diagnóstico (Màster oficial) - 'Master del Sida' - Universidad de Barcelona.
Máster Universitario de Investigación Clínica (Màster oficial) - Investigación Clínica por la Universidad de Barcelona(2) - Universidad de Barcelona.
Máster Universitario de Investigación Clínica (Màster oficial) - Investigación Clínica por la Universidad de Barcelona(2) - Universidad de Barcelona.
Máster en Monitorización de Ensayos Clínicos (Màster Propi) - Máster en Monitorización de Ensayos Clínicos - ESAME: Pharmaceutical Business Schoole.
Máster de Sida Curso Básico de Sida: clínica, tratamiento y virología. Tratamiento del VHB y VHC en pacientes coinfectados VIH. VIH y hepatitis. Epidemiología y Diagnóstico (Màster oficial) - 'Master del Sida' - Universidad de Barcelona.
Máster de los Departamentos Científicos de la Industria Farmacéutica (Màster propi) - Máster de los Departamentos Científicos de la Industria Farmacéutica - Universidad de Barcelona.
Formes farmacèutiques, Farmacologia, Enginyeria Biomèdica (Grau) - Enginyeria Biomèdica - Universidad de Barcelona.

Formació acadèmica

Llicenciat en Medicina i Cirurgia . Universitat de Barcelona . 19/07/1989 . (Diplomatura / Llicenciatura / Grau)
Especialista en Farmacologia Clínica . Hospitals Vall d'Hebron . 1994 . (Diplomatura / Llicenciatura / Grau)
Doctor . Universitat de Barcelona . 05/07/2006 . (Doctorat )
Doctor . Universitat de Barcelona . 29/09/2015 . (Màster Oficial)

Publicacions en revistes

Gassó, P.; Mas, S.; Papagianni, K.; Ferrando, E.; Fernández de Bobadilla, R.; Arnaiz, J.A.; Bernardo, M.; Lafuente, A. (2014). Effect of CYP2D6 on risperidone pharmacokinetics and extrapyramidal symptoms in helathy volunteers: results from a pharmacogenetic clinical trial. Pharmacogenomics, 15(1), pp. 17 - 28 . https://doi.org/10.2217/pgs.13.204 . ISSN: 1462-2416
Gassó, P.; Papagianni, K.; Mas, S.; Fernández de Bobadilla, R.; Arnaiz, JA.; Bernardo, M.; Lafuente, A. (2013). Relationship between CYP2D6 genotype and haloperidol pharmacokinetics and extrapyramidal symptoms in healthy volunteers. Pharmacogenomics, 14(13), pp. 1551 - 1563 . https://doi.org/10.2217/pgs.13.150 . ISSN: 1462-2416
Maduell, F.; Moreso, F.; Pons, M.; Ramos, R.; Mora-Macià, J.; Carreras, J.; Soler, J.; Torres, F.; Campistol, J.M.; Martinez-Castelao, A. (2013). High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. Journal of the American Society of Nephrology, 24(3), pp. 487 - 497 . https://doi.org/10.1681/ASN.2012080875 . ISSN: 1046-6673
Mothe B; Climent N; Plana M; Rosas M; Jimenez JL; Muñoz-Fernandez MA; Puertas MC; Carrillo J; Gonzalez N; Leon A; Pich J; Arnaiz JA; Gatell JM; Clotet B; Blanco J; Alcamí J; Martinez-Picado J; Alvarez-Fernandez C; Sanchez-Palomino S; Guardo AC; Peña J; Benito J; Rallón N; Gomez C; Perdiguero B; Garcia-Arraiza J; Esteban M; López J; Brander C; Garcia F; (2015). Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1. Journal of Antimicrobial Chemotherapy, 70, pp. 1833 - 1842 . ISSN: 0305-7453
Llufriu S; Sepúlveda M; Blanco Y; Marín P; Moreno B; Berenguer J; Gabilondo I; Martínez-Heras E; Sola-Valls N; Arnaiz JA; Andreu EJ; Fernández B; Bullich S; Sánchez-Dalmau B; Graus F; Villoslada P; Saiz A. (2014). Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis. PLoS One, 9(12), p. e113936 . Repositori Institucional . ISSN: 1932-6203
Leal, L.; Leon, A.; Torres, B.; Inciarte, A.; Lucero, C.; Mallolas, J.; Laguno, M.; Martinez-Rebollar, M.; Gonzalez-Cordon, A.; Manzardo, C.; Rojas, J.; Pich. J.; Arnaiz, J.A.; Gatell, J.M.; Garcia. F.; Espinosa, G. (Collab.) (2016). A randomized clinical trial comparing ritonavir-boosted lopinavir versus maraviroc each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection. Journal of Antimicrobial Chemotherapy . https://doi.org/10.1093/jac/dkw048 . ISSN: 0305-7453
Castellano JM; Sanz G; Peñalvo JL; Bansilal S; Fernández-Ortiz A; Alvarez L; Guzmán L; Juan Carlos Linares JC; García F; D'Aniello F; Arnaiz JA; Varea S; Martínez F; Lorenzatti A; Imaz I; Sánchez-Gómez LM; Roncaglioni MC; Baviera M; Smith SC; Taubert K; Pocock S; Brotons C; Farkouh ME; MD; Fuster V. (2014). A Polypill Strategy to Improve Adherence. Results From the FOCUS Project. Journal of the American College of Cardiology, 64, pp. 2071 - 2082 . ISSN: 0735-1097
Torres, B.; Rallón, N.I.; Loncá, M.; Díaz, A.; Alós, L.; Martínez, E.; Cruceta, A.; Arnaiz, J.A.; Leal, L.; Lucero, C.; León, A.; Sánchez, M.; Negredo, E.; Clotet, B.; Gatell, J.M.; Benito, J.M.; Garcia, F. (2014). Immunological function restoration with Lopinavir/ritonavir vs Efavirenz containing regimens in HIV infected patients: a randomized clinical trial. Aids Research and Human Retroviruses, 30(5), pp. 425 - 433 . Repositori Institucional . ISSN: 0889-2229
Blázquez, A.; Mas, S.; Plana, M.T.; Gassó, P.; Mendez, I.; Torra, M.; Arnaiz, J.A.; Lafuente, A.; Lázaro, L. (2014). Plasma fluoxetine concentrations and clinical improvement in an adolescent sample diagnosed with major depressive disorder, obsessive-compulsive disorder, or generalized anxiety disorder. Journal of Clinical Psychopharmacology, 34(3), pp. 318 - 326 . https://doi.org/10.1097/JCP.0000000000000121 . ISSN: 0271-0749
Mas, S.; Gassó, P.; Fernández, R.; Arnaiz, JA.; Bernardo, M.; Lafuente, A. (2013). Secondary nonmotor negative symptoms in healthy volunteers after single doses of haloperidol and risperidone: a double-blind, crossover, placebo-controlled trial. Human Psychopharmacology-Clinical and Experimental, 28(6), pp. 586 - 593 . https://doi.org/10.1002/hup.2350 . ISSN: 0885-6222
Abraldes, J.G.; Villanueva, C.; Aracil, C.; Turnes, J.; Hernandez-Guerra, M.; Genesca, J.; Rodriguez, M.; Castellote, J.; García-Pagán, J.C.; Torres, F.; Calleja, J.L.; Albillos, A.; Bosch, J. (2016). Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis. Gastroenterology, 150(5), pp. 1160 - 1170 . https://doi.org/10.1053/j.gastro.2016.01.004 . ISSN: 0016-5085
Pett SL; Amin J; Horban A; Andrade-Villanueva J; Losso M; Porteiro N; Sierra Madero J; Belloso W; Tu E; Silk D; Kelleher A; Harrigan R; Clark A; Sugiura W; Wolff M; Gill J; Gatell J; Fisher M; Clarke A; Ruxrungtham K; Prazuck T; Kaiser R; Woolley I; Arnaiz JA; Cooper D; Rockstroh JK; Mallon P; Emery S; MARCH study group. (2016). Maraviroc, as a switch option, in HIV-1 infected individuals with stable, well-controlled HIV replication and R5-tropic virus on their first N(t)RTI+PI/r regimen. Week 48 results of the randomised, multicentre MARaviroc switCH study (MARCH). Clinical Infectious Diseases . ISSN: 1058-4838
Gasso, Patricia; Rodriguez, Natalia; Blazquez, Ana; Monteagudo, Ana; Boloc, Daniel; Teresa Plana, Maria; Lafuente, Amalia; Lazaro, Luisa; Albert Arnaiz, Joan; Mas, Sergi (2017). Epigenetic and genetic variants in the HTR1B gene and clinical improvement in children and adolescents treated with fluoxetine. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 75, pp. 28 - 34 . https://doi.org/10.1016/j.pnpbp.2016.12.003 . ISSN: 0278-5846
Mas, Sergi; Blazquez, Ana; Rodriguez, Natalia; Boloc, Daniel; Lafuente, Amalia; Arnaiz, Joan A.; Lazaro, Luisa; Gasso, Patricia (2016). Pharmacogenetic study focused on fluoxetine pharmacodynamics in children and adolescent patients: impact of the serotonin pathway. Pharmacogenetics and Genomics, 26(11), pp. 487 - 496 . https://doi.org/10.1097/FPC.0000000000000240 . ISSN: 1744-6872
Palacio M; Cobo T.; Antolín E.; Ramirez M.; Cabrera F.; Mozo de Rosales F.; Bartha JL.; Juan M; Martí A.; Oros D.; Rodríguez À.; Scazzocchio E.; Olivares JM.; Varea S.; Ríos J.; Gratacós E. (2016). Vaginal progesterone as maintenance treatment after an episode of preterm labour (PROMISE) study: a multicentre, double-blind, randomised, placebo-controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology, 123(12), pp. 1990 - 1999 . https://doi.org/10.1111/1471-0528.13956 . ISSN: 1470-0328
Inciarte, A.; Leal, L.; González, E.; León, A.; Lucero, C.; Mallolas, J.; Torres, B.; Laguno, M.; Rojas, J.; Martínez-Rebollar, M.; González-Cordón, A.; Cruceta, A.; Arnaiz, J.A.; Gatell, J.M.; García, F.; Blanco, J.L.; Martínez, E.; Miró, J.M.; Laguno, M.; Manzardo, C.; de la Calle, C.; Espinosa, G.; Arnaiz, J.A.; Pericas, J.M.; Nicolás, D.; Bodro, M.; Del Río, A.; Cardozo, C. (2017). Tenofovir disoproxil fumarate/emtricitabine plus ritonavir-boosted lopinavir or cobicistat-boosted elvitegravir as a single-tablet regimen for HIV post-exposure prophylaxis. Journal of Antimicrobial Chemotherapy, 72(10), pp. 2857 - 2861 . https://doi.org/10.1093/jac/dkx246 . ISSN: 0305-7453
Gasso, Patricia; Rodriguez, Natalia; Boloc, Daniel; Blazquez, Ana; Torres, Teresa; Gortat, Ana; Teresa Plana, Maria; Lafuente, Amalia; Mas, Sergi; Albert Arnaiz, Joan; Lazaro, Luisa (2017). Association of regulatory TPH2 polymorphisms with higher reduction in depressive symptoms in children and adolescents treated with fluoxetine. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 77, pp. 236 - 240 . https://doi.org/10.1016/j.pnpbp.2017.04.031 . ISSN: 0278-5846
Mas, S.; Gassó, P.; Fernández, R.; Arnaiz, JA.; Bernardo, M.; Lafuente, A. (2013). Secondary nonmotor negative symptoms in healthy volunteers after single doses of haloperidol and risperidone: a double-blind, crossover, placebo-controlled trial. Human Psychopharmacology-Clinical and Experimental, 28(6), pp. 586 - 593 . https://doi.org/10.1002/hup.2350 . ISSN: 0885-6222
Gassó, P.; Mas, S.; Papagianni, K.; Ferrando, E.; Fernández de Bobadilla, R.; Arnaiz, J.A.; Bernardo, M.; Lafuente, A. (2014). Effect of CYP2D6 on risperidone pharmacokinetics and extrapyramidal symptoms in helathy volunteers: results from a pharmacogenetic clinical trial. Pharmacogenomics, 15(1), pp. 17 - 28 . https://doi.org/10.2217/pgs.13.204 . ISSN: 1462-2416
Gasso, P.; Mas, S.; Papagianni, K.; Ferrando, E.; Fernández, R.; Arnaiz, J.A.; Bernardo, M.; Lafuente, A. (2014). Effect of cytochrome P450 2D6 on risperidone pharmacokinetics and extrapyramidal symptoms in healthy volunteers; results from a pharmacogenetic clinical trial. Pharmacogenomics, 15(1), pp. 17 - 28 . ISSN: 1462-2416
Gasso, P.; Mas, S.; Papagianni, K.; Ferrando, E.; Fernández, R.; Arnaiz, J.A.; Bernardo, M.; Lafuente, A. (2014). Effect of cytochrome P450 2D6 on risperidone pharmacokinetics and extrapyramidal symptoms in healthy volunteers; results from a pharmacogenetic clinical trial. Pharmacogenomics, 15(1), pp. 17 - 28 . ISSN: 1462-2416
Gassó, P.; Mas, S.; Papagianni, K.; Ferrando, E.; Fernández de Bobadilla, R.; Arnaiz, JA.; Bioque, M.; Bernardo, M; Lafuente, A. (2013). Effect of cytochrome P450 2D6 on risperidone pharmacokinetics and extrapyramidal symptoms in healthy volunteers: results from a pharmacogenetic clinical trial. Pharmacogenomics, 113(2), pp. 22 - 22 . ISSN: 1462-2416
Blazquez, A.; Arnaiz, J.A.; Mas, S.; Plana, M.T.; Gassó, P.; Méndez, I.; Lafuente, A.; Lázaro, L. (2013). Clinical improvement, age, gender and serum concentration of active moiety (fluoxetine + norfluoxetine) in MDD patients. European Child & Adolescent Psychiatry, 22(Supl2), pp. S270 - S270 . ISSN: 1018-8827
Lafuente, A.; Gassó, P.; Mas, S.; Papagianni, K.; Ferrando, E.; Fernández de Bobadilla, R.; Arnaiz, J.A.; Bioque, M.; Bernardo, M. (2013). Effect of cytochrome p450 2D6 on risperidone pharmacokinetics and extrapyramidal symptoms in healthy volunteers: results from a pharmacogenetic clinical trial. Basic & Clinical Pharmacology & Toxicology, 113(Supl1), p. 48 . ISSN: 1742-7835
Lafuente, A.; Gassó, P.; Mas, S.; Papagianni, K.; Ferrando, E.; Fernández de Bobadilla, R.; Arnaiz, J.A.; Bioque, M.; Bernardo, M. (2013). Effect of cytochrome p450 2D6 on risperidone pharmacokinetics and extrapyramidal symptoms in healthy volunteers: results from a pharmacogenetic clinical trial. Basic & Clinical Pharmacology & Toxicology, 113(Supl1), p. 48 . ISSN: 1742-7835
Lafuente, A.; Gasso, P.; Papagianni, K,; Mas, S.; de Bobadilla, R.F.; Arnaiz, J.A.; Bernardo, M. (2014). Relationship between CYP2D6 genotype and haloperidol pharmacokinetics and extrapyramidal symptoms in healthy volunteers. Basic & Clinical Pharmacology & Toxicology, 115(Supl2), p. 52 . ISSN: 1742-7835
Gasso, Patricia; Rodriguez, Natalia; Blazquez, Ana; Monteagudo, Ana; Boloc, Daniel; Teresa Plana, Maria; Lafuente, Amalia; Lazaro, Luisa; Albert Arnaiz, Joan; Mas, Sergi (2017). Epigenetic and genetic variants in the HTR1B gene and clinical improvement in children and adolescents treated with fluoxetine. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 75, pp. 28 - 34 . https://doi.org/10.1016/j.pnpbp.2016.12.003 . ISSN: 0278-5846
Leal, Lorna; Leon, Agathe; Torres, Berta; Inciarte, Alexy; Lucero, Constanza; Mallolas, Josep; Laguno, Montserrat; Martinez-Rebollar, Maria; Gonzalez-Cordon, Ana; Manzardo, Christian; Rojas, Jhon; Pich, Judit; Arnaiz, Joan A.; Gatell, Josep M.; Garcia, Felipe (2016). A randomized clinical trial comparing ritonavir-boosted lopinavir versus raltegravir each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection. Journal of Antimicrobial Chemotherapy, 71(7), pp. 1987 - 1993 . https://doi.org/10.1093/jac/dkw049 . ISSN: 0305-7453
Leal, Lorna; Guardo, Alberto C.; Moron-Lopez, Sara; Salgado, Maria; Mothe, Beatriz; Heirman, Carlo; Pannus, Pieter; Vanham, Guido; van den Ham, Henk Jan; Gruters, Rob; Andeweg, Arno; Van Meirvenne, Sonja; Pich, Judit; Arnaiz, Joan Albert; Gatell, Josep M.; Brander, Christian; Thielemans, Kris; Martinez-Picado, Javier; Plana, Montserrat; Garcia, Felipe (2018). Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection. AIDS, 32(17), pp. 2533 - 2545 . https://doi.org/10.1097/QAD.0000000000002026 . ISSN: 0269-9370
Barroso, S.; Morén, C.; González-Segura, A.; Riba, N.; Arnaiz, J.A.; Manriquez, M.; Santana, G.; Blanco, J.L.; Larousse, M.; Loncà, M.; de Lazzari, E.; Llopis, J.; Mallolas, J.; Miró, O., Carné, X.; Gatell, J.M.; Garrabou, G.; Martínez, E. (2019). Metabolic, mitochondrial, renal and hepatic safety of enfuvirtide and raltegravir antiretroviral administration: Randomized crossover clinical trial in healthy volunteers. PLoS One, 14(5), p. e0216712 . Repositori Institucional . ISSN: 1932-6203
de Jong, Wesley; Aerts, Joeri; Allard, Sabine; Brander, Christian; Buyze, Jozefien; Florence, Eric; van Gorp, Eric; Vanham, Guido; Leal, Lorna; Mothe, Beatriz; Thielemans, Kris; Plana, Montse; Garcia, Felipe; Gruters, Rob; Garcia, Felipe; Gatell, Jose M.; Arnaiz, Joan-Albert; Plana, Montse; Leal, Lorna; Guardo, Albert; Maleno, Maria Jose; Vanham, Guido; Florence, Eric; Pannus, Pieter; Buyze, Jozefien; Heyndrickx, Leo; Thielemans, Kris; Aerts, Joeri; Allard, Sabine; Tjok, Patrick; Brander, Christian; Mothe, Beatriz; Martinez-Picado, Javier; Olvera, Alex; Rosas, Miriam; Salgado, Maria; Moron, Sara; Molto, Jose; Lopez, Miriam; Gruters, Rob; Koopmans, Marion; de Jong, Wesley; Boers, Patrick; Scheuer, Rachel; Lungu, Cynthia; Heirman, Carlo; Van Meirvenne, Sonja; Graupera, Anna; Honrado, Angel (2019). iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy. Trials, 20(361) . Repositori Institucional . ISSN: 1745-6215
Guardo, Alberto C.; Elena Gomez, Carmen; Diaz-Brito, Vicens; Pich, Judit; Albert Arnaiz, Joan; Perdiguero, Beatriz; Garcia-Arriaza, Juan; Gonzalez, Nuria; Sorzano, Carlos O. S.; Jimenez, Laura; Luis Jimenez, Jose; Angeles Munoz-Fernandez, Maria; Gatell, Jose M.; Alcam, Jose; Esteban, Mariano; Bernaldo de Quiros, Juan Carlos Lopez; Garcia, Felipe; Plana, Montserrat (2017). Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization. PLoS One, 12(10), p. e0186602 . Repositori Institucional . ISSN: 1932-6203
Rodríguez, N; Mas, S; Blázquez, A; Boloc, D; Lafuente, A; Arnaiz, JA; Lázaro, L; Gassó, P (2017). Pharmacogenetic study focused on fluoxetine pharmacodynamics in children and adolescent patients: Impact of the serotonin pathway. Basic & Clinical Pharmacology & Toxicology, 121(suppl 2), p. 67 . ISSN: 1742-7835
Gassó, P; Rodríguez, N; Blázquez, A; Monteagudo, A; Boloc, D; Plana, MT; Lafuente, A; Lázaro, L; Arnaiz, JA; Mas, S (2017). Epigenetic and genetic variants in the HTR1B gene and clinical improvement in children and adolescents treated with fluoxetine. Basic & Clinical Pharmacology & Toxicology, 121(suppl 2), p. 68 . ISSN: 1742-7835
Gassó, P.; Arnaiz, J.A.; Mas, S.; Lafuente, A.; Bioque, M.; Cuesta, M.J.; Díaz-Caneja, C.M.; García, C.; Lobo, A.; González-Pinto, A.; Parellada, M.; Corripio, I.; Vieta, E.; Castro-Fornieles, J.; Mané, A.; Rodríguez, N.; Boloc, D.; Saiz-Ruiz, J.; Bernardo, M.; PEPs Group. (2020). Association study of candidate genes with obesity and metabolic traits in antipsychotic-treated patients with first-episode psychosis over a 2-year period. Journal of Psychopharmacology, 34(5), pp. 514 - 523 . https://doi.org/10.1177/0269881120903462 . ISSN: 0269-8811
Martínez-Pinteño, A.; García-Cerro, S.; Mas, S.; Torres,T.; Boloc, D.; Rodríguez, N.; Lafuente, A.; Gassó, P.; Arnaiz, J.A.; Parellada, E. (2020). The positive allosteric modulator of the mGlu2 receptor JNJ-46356479 partially improves neuropathological deficits and schizophrenia-like behaviors in a postnatal ketamine mice model. Journal of Psychiatric Research, 126, pp. 8 - 18 . https://doi.org/10.1016/j.jpsychires.2020.04.005 . ISSN: 0022-3956
Arnaiz, J.A.; Rodrigues-Silva, C.; Mezquida, G.; Amoretti, S.; Cuesta, M.J.; Fraguas, D.; Lobo, A.; González-Pinto, A.; Díaz-Caneja, M.C.; Corripio, I.; Vieta, E.; Baeza, I.; Mané, A.; García-Rizo, C.; Bioque, M.; Saiz, J.; Bernardo, M.; Mas, S.; PEPs group. (2021). The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis. Psychopharmacology, 238(3), pp. 665 - 676 . https://doi.org/10.1007/s00213-020-05715-5 . ISSN: 0033-3158
Boloc, D.; Rodríguez, N.; Torres, T.; García-Cerro, S.; Parellada, M.; Saiz-Ruiz, J.; Cuesta, M.J.; Bernardo, M.; Gassó, P.; Lafuente, A.; Mas, S.; Arnaiz, J.A. (2020). Identifying key transcription factors for pharmacogenetic studies of antipsychotics induced extrapyramidal symptoms. Psychopharmacology, 237(7), pp. 2151 - 2159 . https://doi.org/10.1007/s00213-020-05526-8 . ISSN: 0033-3158
Torres, T.; Boloc, D.; Rodríguez, N.; Blázquez, A.; Plana, M.T.; Varela, E.; Gassó, P.; Martinez-Pinteño, A.; Lázaro, L.; Arnaiz, J.A.; Mas, S. (2020). Response to fluoxetine in children and adolescents: a weighted gene co-expression network analysis of peripheral blood. American Journal Of Translational Research, 12(5), pp. 2028 - 2040 . Repositori Institucional . ISSN: 1943-8141
Ducrocq G, Gonzalez-Juanatey JR, Puymirat E, Lemesle G, Cachanado M, Durand-Zaleski I, Arnaiz JA, Martínez-Sellés M, Silvain J, Ariza-Solé A, Ferrari E, Calvo G, Danchin N, Avendaño-Solá C, Frenkiel J, Rousseau A, Vicaut E, Simon T, Steg PG; REALITY Investigators. (2021). Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial. JAMA-Journal of the American Medical Association . ISSN: 0098-7484
Gonzalez-Juanatey JR; Lemesle G; Puymirat E; Ducrocq G; Cachanado M; Arnaiz JA; Martínez-Sellés M; Silvain J; Ariza-Solé A; Ferrari E; Calvo G; Danchin N; Avendano-Solá C; Rousseau A; Vicaut E; Gonzalez-Ferrero T; Steg PG; Simon T; REALITY Investigators. (2022). One-Year Major Cardiovascular Events After Restrictive Versus Liberal Blood Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Trial. Circulation, 145(6), pp. 486 - 488 . ISSN: 0009-7322
Torres, T.; Boloc, D.; Rodríguez, N.; Blázquez, A.; Plana, M.T.; Varela, E.; Gassó, P.; Martinez-Pinteño, A.; Lázaro, L.; Arnaiz, J.A.; Mas, S. (2020). Response to fluoxetine in children and adolescents: A weighted gene co-expression network analysis of peripheral blood. American Journal Of Translational Research, 12(5), pp. 2028 - 2040 . ISSN: 1943-8141